Double-Stranded DNA Antibodies (dsDNA)
Here’s what it reflects — and what to do about it.
Longetic pulls together every lab and record you’ve had, follows how Double-Stranded DNA Antibodies (dsDNA) changes over time, and explains what’s shifting — so you walk into your next appointment prepared, with reminders for retests along the way.
What is Double-Stranded DNA Antibodies (dsDNA)?
Anti-double-stranded DNA (dsDNA) antibodies target DNA directly and are one of the most specific blood markers for systemic lupus erythematosus.
Anti-dsDNA antibodies target double-stranded DNA and are among the most specific autoantibodies for systemic lupus erythematosus, often appearing alongside a homogeneous ANA pattern. Unlike many other autoantibodies, dsDNA levels can rise and fall with disease activity, and higher levels have been associated with kidney involvement, known as lupus nephritis. Clinicians commonly order this test together with ANA, complement C3 and C4, and clinical symptoms both to help support a lupus diagnosis and, once diagnosed, to help follow disease activity over time. A positive result is one important clue interpreted within this broader clinical and laboratory picture rather than a stand-alone diagnosis.
Lifestyle factors that influence this marker
- Aim for a balanced, anti-inflammatory eating pattern with plenty of vegetables, fruit, and healthy fats
- Protect skin from excess sun exposure
- Stay physically active with regular moderate exercise
- Prioritize consistent, restorative sleep
- Practice stress-management techniques
- Avoid smoking
Tests often checked alongside this
- ANA Pattern and ANA Titer — often positive together with dsDNA antibodies
- Complement C3 and Complement C4 — commonly tracked together to help gauge disease activity
- Chromatin Antibody — another lupus-associated marker frequently checked together
How this can show up in how you look and feel
- May be associated with joint pain
- May be associated with skin rashes, including sun-sensitive rashes
- May be associated with fatigue
- May be associated with changes suggestive of kidney involvement, such as swelling
What can affect this marker
- Age
- Sex
- Medications
- Lab variability between testing methods
What to track over time
- Whether levels rise or fall alongside disease activity and symptoms
- How dsDNA trends align with complement C3 and C4 levels over time
- Whether repeat testing is considered during suspected flares
What to ask your doctor
- How does this result relate to my ANA and complement levels?
- Could this be relevant to how my kidneys are doing?
- Should this be tracked over time alongside my symptoms?
- Is any follow-up testing or monitoring recommended?
This glossary entry is for informational purposes only and is not a substitute for professional medical advice. Read our Terms of Use.
References
About our sources
Official sources
Government health agencies, national institutes, and intergovernmental bodies whose guidelines carry regulatory or policy weight.
Clinical / professional
Medical societies, specialty colleges, and professional associations whose consensus statements reflect clinical practice standards.
Peer-reviewed research
Original research articles and systematic reviews published in indexed journals and verified through PubMed or DOI.